Biotronik

Biotronik

Biotronik is a leading medical device company that has been developing innovative cardiovascular and endovascular solutions for more than 50 years. Biotronik is headquartered in Berlin, Germany, and represented in over 100 countries. OMEICOS had implemented Biotronik’s insertable cardiac monitor BioMonitor 2 into the study design of the Phase 2 clinical trial of OMT-28 in persistent Atrial Fibrillation to accurately detect and monitor arrhythmias.